AbbVie Shares Outstanding 2012-2026 | ABBV

AbbVie shares outstanding for the quarter ending March 31, 2026 were 1.774B, a 0.11% increase year-over-year.

  • AbbVie 2025 shares outstanding were 1.773B, a 0% decline from 2024.
  • AbbVie 2024 shares outstanding were 1.773B, a 0% decline from 2023.
  • AbbVie 2023 shares outstanding were 1.773B, a 0.28% decline from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

AbbVie Shares Outstanding 2012-2026 | ABBV

  • AbbVie 2025 shares outstanding were 1.773B, a 0% decline from 2024.
  • AbbVie 2024 shares outstanding were 1.773B, a 0% decline from 2023.
  • AbbVie 2023 shares outstanding were 1.773B, a 0.28% decline from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B